.svg)
Content management in life sciences is the governed handling of regulated documents and media across pharma, biotech, and medical-device operations, research records, clinical trial documentation, regulatory submissions, quality records, and promotional material, under frameworks like GxP, 21 CFR Part 11, and health-authority submission standards, where every document's integrity and audit history must be provable.
Life sciences content lives under strict controls: 21 CFR Part 11 governs electronic records and signatures (validated systems, audit trails, signature integrity); GxP disciplines demand version control and defensible change history; and submission standards dictate structure and format for regulatory filings. A document's provenance, who created, reviewed, and approved it, and when, is itself regulated data, not metadata.
The volume and criticality make manual control untenable: a single submission assembles thousands of documents that must be current, approved, and traceable. Systems must enforce audit-trailed, controlled workflows, maintain immutable audit trails, control promotional material through medical-legal-regulatory (MLR) review, and increasingly manage rich media, scientific imaging, procedure video, patient-facing content, with the same rigor as text.
ioMoVo provides permission-controlled content management for life sciences, audit-trailed, controlled workflows, immutable logging, and rich-media handling, deployable on-premises or air-gapped where research and patient data cannot leave controlled infrastructure. See the ioMoVo life sciences page.
The FDA regulation governing electronic records and signatures, requiring validated systems, audit trails, and controls that make electronic records as trustworthy as paper.
Medical, legal, and regulatory review of promotional content before use, a controlled, documented approval workflow content systems must enforce.